News

Here goes some nice category description. Good for SEO.

Imfinzi combo gets ODD; Mayzent gets EU nod; Positive results of VP-102

Business Consultant, News, Pharma Consultant

The US FDA has recently granted Orphan Drug Designation to AstraZeneca’s Imfinzi (durvalumab) and tremelimumab, combination therapy for...

Read More

Eli Lilly to acquire Dermira, Boehringer buys Enleofen’s IL-11 platform, Biogen acquires Pfizer’s Alzheimer’s drug

Business Consultant, News, Pharma Consultant, Pharma news

Eli Lilly has announced to buy a biopharmaceutical company, Dermira, for a whopping sum of USD 1.1 Billion in an all-cash transaction....

Read More
Close